Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: a stochastic economic evaluation.

Karnon, Jonathan

Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: a stochastic economic evaluation. [electronic resource] - PharmacoEconomics 2002 - 119-37 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1170-7690

10.2165/00019053-200220020-00005 doi


Aged
Anticarcinogenic Agents--adverse effects
Antineoplastic Agents--adverse effects
Breast Neoplasms--drug therapy
Cost-Benefit Analysis
Disease Progression
Female
Humans
Middle Aged
Models, Economic
Reproducibility of Results
Tamoxifen--adverse effects